Herbalife Reports Third Quarter 2024 Results, Net Sales In Line with Expectations, Adjusted EBITDA¹ Exceeds Guidance; Raised Full-Year Adjusted EBITDA¹ Guidance

Go back to Herbalife Reports Third Quarter 2024 Results, Net Sales In Line with Expectations, Adjusted EBITDA¹ Exceeds Guidance; Raised Full-Year Adjusted EBITDA¹ Guidance
HERBALIFE LTD. (NYSE: HLF) Delayed: 13.71 -0.06 (0.44%)
Previous Close $13.77    52 Week High $72.22 
Open $13.76    52 Week Low $42.26 
Day High $13.85    P/E 2.79 
Day Low $13.54    EPS $4.91 
Volume 1,396,028